Physician profile

Christopher K Tidwell

Pulmonary Disease · Columbus, GA

NPI 1114032323

$6,253.67

in general payments reported to CMS, 2019-2025

38 companies · none reported in 2025

See the full distribution for Pulmonary Disease

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$1,977.68

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Glaxosmithkline, LLC. $2,053.01 2019-2024 Trelegy Ellipta, Nucala, Arexvy
Astrazeneca Pharmaceuticals LP $954.29 2019-2024 Tezspire, Breztri, Airsupra
Boehringer Ingelheim Pharmaceuticals, INC. $602.60 2019-2024 Ofev
Regeneron Healthcare Solutions, INC. $490.72 2019-2024 Dupixent
Insmed, INC. $443.55 2019-2024 Arikayce
Genzyme Corporation $250.75 2022-2024
Takeda Pharmaceuticals U.S.A., INC. $183.46 2020-2024 Glassia
Inspire Medical Systems, INC. $139.15 2024 Inspire
Inogen, INC. $133.50 2022-2023 Inogen One G5 Oxygen Concentrator - Bluetooth
Mylan Specialty L.P. $126.90 2019-2024 Yupelri
United Therapeutics Corporation $104.04 2021
Circassia INC. $101.30 2019-2020
Grifols USA, LLC $63.56 2022
Merck Sharp & Dohme LLC $61.93 2022-2023
Mallinckrodt Hospital Products INC. $60.31 2022-2023 Acthar
Show all 38 companies
CompanyGeneral paymentsYearsTop products
Advanced Respiratory, INC $42.61 2020-2021
Shire North American Group INC $37.26 2019
Actelion Pharmaceuticals US, INC. $34.41 2020-2021
Therapeuticsmd, INC. $33.79 2020
Amgen INC. $31.39 2022-2024 Tezspire
Pfizer INC. $29.74 2021-2023
Teva Pharmaceuticals USA, INC. $26.74 2021-2022
Baxter Healthcare $24.15 2024 Hillrom - Vest System Model 105 Home Care
Horizon Therapeutics Plc $23.09 2020
Olympus America INC. $19.21 2021
Adma Biomanufacturing LLC $17.92 2021
La Jolla Pharmaceutical Company $16.34 2023 Giapreza
Ambu INC. $15.56 2024
Electromed, INC. $14.53 2021
Gilead Sciences, INC. $14.13 2019
Allergan, INC. $13.82 2019
Bayer Healthcare Pharmaceuticals INC. $13.67 2019
E.R. Squibb & Sons, L.L.C. $13.66 2021
Paratek Pharmaceuticals, INC. $13.61 2023 Nuzyra
Boston Scientific Corporation $12.91 2019
Mallinckrodt Enterprises LLC $12.09 2019
Genentech USA, INC. $12.07 2021
Avion Pharmaceuticals $11.90 2020

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Christopher K Tidwell

$6,253.67

in general payments reported 2019-2025

Years
2019-2024
Top company
Glaxosmithkline, LLC.

https://glasscript.com/doctor/231973/christopher-k-tidwell

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.